Related Experiment Video
Updated: Jan 10, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Ultra-Processed Food Consumption and Irritable Bowel Syndrome: Current Evidence and Clinical Implications
Hanna Fjeldheim Dale1, Marit Kolby2, Jørgen Valeur1,3
1Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, 0456 Oslo, Norway.
Ultra-processed food consumption may increase the risk of irritable bowel syndrome (IBS), a gut-brain interaction disorder. Reducing ultra-processed foods may help manage IBS symptoms by improving gut health.
Area of Science:
- Gastroenterology and Nutrition Science
Background:
- Irritable bowel syndrome (IBS) is a common gut-brain interaction disorder impacting quality of life.
- Global consumption of ultra-processed foods (UPF) is rising, with links to chronic diseases.
Purpose of the Study:
- To review evidence on the association between UPF consumption and IBS.
- To explore mechanistic insights and clinical implications.
Main Methods:
- Narrative review synthesizing epidemiological, experimental, and clinical studies.
- Analysis of observational data on UPF intake and IBS risk.
- Examination of mechanistic pathways involving food additives.
Main Results:
- Observational studies suggest higher UPF intake correlates with increased IBS risk, though evidence is limited.
- Mechanistic studies show UPF additives can alter gut microbiota, impair intestinal barrier, and promote inflammation.
- Current evidence indicates a potential link between UPF and IBS.
Conclusions:
- Reducing UPF intake and improving dietary quality are potential complementary strategies for IBS management.
- Further intervention trials are needed to confirm the link and explore underlying biological mechanisms.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS

